论文部分内容阅读
目的探讨管状胃代食管术与全胃代食管术治疗食管癌的临床效果。方法随机选取2014年2月至2015年2月92例食管癌患者作为研究对象,按手术方法的不同分为研究组和对照组,每组46例。研究组行管状胃代食管术治疗,对照组行全胃代食管术治疗,对比两组患者的临床治疗效果、术中出血量、手术时间、住院时间、胃肠减压时间以及术后并发症。结果两组术中出血量、手术时间、住院时间以及胃肠减压时间等指标比较差异未见统计学意义(P>0.05)。研究组术后发生反流性食管炎占2.17%,明显低于对照组(6.52%);研究组术后未发生胸胃综合征,对照组发生胸胃综合征者占10.87%;研究组术后并发症发生率为8.7%,对照组为30.43%,对照组术后并发症显著高于研究组,差异有统计学意义(P<0.05)。结论在食管癌的治疗中采用管状胃代食管术较全胃代食管术治疗更有效,能降低患者术后并发症,提高治疗有效率,术后对患者呼吸功能影响较小,值得临床推广和应用。
Objective To investigate the clinical effect of tubular gastric esophageal esophageal surgery and total esophageal esophagectomy on esophageal cancer. Methods A total of 92 patients with esophageal cancer from February 2014 to February 2015 were randomly divided into study group and control group with 46 cases in each group. The study group was treated with tubular gastric esophageal surgery, while the control group with total stomach esophageal esophagectomy. The clinical effects, intraoperative blood loss, operation time, hospitalization time, decompression time and postoperative complications were compared between the two groups . Results There was no significant difference between the two groups in the amount of bleeding, operation time, hospitalization time and decompression time of gastrointestinal (P> 0.05). The postoperative reflux esophagitis accounted for 2.17% in the study group, which was significantly lower than that in the control group (6.52%). There was no thorax gastric syndrome in the study group and 10.87% in the control group. The study group The postoperative complication rate was 8.7% in the control group and 30.43% in the control group. The postoperative complications in the control group were significantly higher than those in the study group (P <0.05). Conclusion In the treatment of esophageal cancer, the use of tubular esophageal esophageal surgery is more effective than total esophageal esophagectomy, which can reduce the postoperative complications and improve the efficiency of treatment. The postoperative impact on the patient’s respiratory function is small, worthy of clinical promotion and application.